Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • cliff
    Member
    • Oct 2009
    • 41

    PCR duplicate removal for whole genome sequencing vs. whole exome sequencing

    Hi

    I did whole-genome sequencing and whole-exome sequencing on a whole-genome amplified (WGA’d) sample and got 2% of reads removed as duplicates by whole-genome sequencing but 80% of reads removed by whole-exome sequencing.

    I then did whole-exome sequencing on an unamplified HapMap control and WGA’d HapMap control and got 25% of reads removed from the unamplified HapMap control and 50% removed from the WGA’d HapMap control.

    I used Illumina standard PE101 whole-genome sequencing protocol for whole-genome sequencing and NimbleGen exome capture (version 2) for exome capture followed by Illumina sequencing.

    Can anyone share some thoughts on the big difference between whole-genome sequencing and whole-exome sequencing of my WGA’d sample in terms of duplicate removal? All your comments will be greatly appreciated!
  • lletourn
    Member
    • Oct 2009
    • 63

    #2
    We had the same issue at the beggining, hitting >60% dupes. We had to start with more dna and use a bit bigger fragment lengths to lower the values. We now typically get 20-30% dups.

    Lets not forget that if you have 100x coverage with 100bp reads the chances of having 2 reads with the same 5' position and/or having 2 fragments having the same sequence is pretty high. So at high coverage many duplicates aren't duplicates.

    How much coverage are you getting?

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM
    • GATTACAT
      Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
      by GATTACAT
      Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
      07-01-2026, 11:43 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 10:26 AM
    0 responses
    9 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-07-2026, 11:05 AM
    0 responses
    33 views
    0 reactions
    Last Post SEQadmin2  
    Working...